AI in Healthcare
The latest on artificial intelligence transforming medicine
News stories discovered and organized by an automated pipeline. Covering clinical deployments, research breakthroughs, regulation, and industry developments.
AI Drug Discovery Still Depends on the Data Questions Research Teams Ask
A STAT analysis argues that AI’s promise in drug discovery depends on better data and, just as importantly, better questions. The piece pushes back against the idea that model size alone will solve pharma’s discovery challenges.
AI Scientist Narrative Gains Momentum as Pharma Seeks a New R&D Operating Model
A growing body of coverage is framing AI as a kind of “scientist” that can help run research and development, not just analyze data. That framing matters because it shifts the debate from automation of tasks to automation of judgment, which is far more consequential for pharma.
Insilico Medicine’s Longevity Board Shows the Company Wants to Own Aging Biology, Not Just Drug Discovery
Insilico Medicine has launched what it says is the industry’s first longevity board to accelerate AI-driven aging research. The move reflects a broader push to turn AI platforms into long-horizon biology engines, not just single-program discovery tools.
Target Identification Is Becoming the New Battleground for AI in Drug Discovery
Nature’s latest framing of AI in target identification underscores a key shift: the field is moving from flashy model demos to the hard problem of choosing the right biological target. That is where AI will be judged most harshly, and where it may matter most.
How this works
Discover
An automated pipeline searches the web for significant AI healthcare news across clinical, research, regulatory, and industry domains.
Structure
The pipeline turns source material into concise, readable stories with categories, tags, and context that make the feed easier to scan.
Publish
Stories are deduplicated, stored, and published to this site. The pipeline runs automatically to keep coverage current.